Europe Blood Glucose Monitor Market

The report "Europe Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Forecast to 2030", is projected to be worth USD 4.75 billion in 2025 and USD 6.85 billion in 2030, registering a CAGR of 7.6% during the forecast period.

Browse 180 market data Tables and 40 Figures spread through 280 Pages and in-depth TOC on "Europe Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-blood-glucose-monitor-market-10882713.html

The Europe blood glucose monitor market is developing in accordance with the priorities of the healthcare systems, which focus on long-term patient care and cost-effectiveness. The demand for blood glucose monitors is fueled by the growing importance of early diagnosis, careful monitoring, and the prevention of complications from diabetes in publicly funded healthcare systems. The growing number of elderly people in Europe, who are more susceptible to Type 2 diabetes and its complications, also contributes to the growing demand for frequent and reliable glucose monitoring, especially in home and outpatient care. However, the adoption of the market is not uniform due to differences in the reimbursement and tendering processes, which may hinder the adoption of new technology.

“Self monitoring blood glucose systems segment captured the largest market share in 2024”

By product type, the Europe blood glucose monitor market is divided into self-monitoring blood glucose (SMBG) systems, continuous glucose monitoring (CGM) systems, professional point-of-care systems, and non-invasive systems. SMBG systems hold the largest market share in 2024, driven by their continued use in the daily management of diabetes in the home and primary care settings in the region. SMBG systems are used extensively in patients with Type 2 diabetes, in the early stages of the disease, and in patients managed by lifestyle changes and oral pharmacologic therapies. Their widespread use is fueled by their support for national diabetes guidelines, the uniform reimbursement of test strips in most European countries, and their ready availability in community pharmacies and hospital distribution channels. Moreover, advances in miniaturized meters, faster testing times, and improved data management capabilities continue to keep SMBG systems relevant for daily glucose monitoring in the region.

“Diabetes management segment is expected to grow at the highest CAGR during the forecast period”

Based on application, the Europe blood glucose monitor market is divided into diabetes management, health and wellness monitoring, and other applications. The diabetes management application is expected to register the highest growth rate between 2025 and 2030. This is driven by the emphasis on diabetes management in the public healthcare systems and the increasing adoption of structured care pathways. In most European nations, the practice of routine glucose monitoring is incorporated into national diabetes guidelines and disease management programs, which helps in optimizing treatment and preventing complications. The growing adoption of continuous glucose monitoring (CGM) in mainstream treatment, especially among insulin-dependent patients, has also contributed to the segmental growth. Additionally, the presence of strong physician support, patient education programs, and access to reimbursed home-based monitoring systems fuel the growth of the diabetes management application segment in the region.

“France is projected to grow at a commendable rate between 2025 and 2030”

France is expected to register the second-highest CAGR in the Europe blood glucose monitor market. The market is driven by a large and steadily growing diabetic population and a strong emphasis on long-term disease management. According to the International Diabetes Federation (IDF) Diabetes Atlas 2025, around 4.11 million adults aged 20–79 in the country were living with diabetes in 2024, representing a prevalence of approximately 9.0%. Rising adoption of self-monitoring and continuous glucose monitoring technologies, supported by favorable reimbursement policies and increasing home-based care, is accelerating market growth. Growing awareness of glycemic control and digital health integration further supports the expansion of blood glucose monitoring solutions in the country.

Key Players

Prominent players in the Europe blood glucose monitor market include Abbott Laboratories (US), Dexcom, Inc. (US), Medtronic (Ireland), Sinocare (China), B.Braun SE (Germany), F. Hoffmann-La Roche Ltd (Switzerland), i-SENS, Inc. (South Korea), Senseonics (US),  Ascensia Diabetes Care Holdings AG (Switzerland), Nipro (Japan), Medical Technology and Devices S.p.A. (Italy), Terumo Corporation (Japan), Nemaura Medical Inc. (UK), LifeScan IP Holdings, LLC (US), and A. Menarini Diagnostics S.r.l (Italy).

Don’t miss out on business opportunities in Europe Blood Glucose Monitor Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/